Infectious Disease

Looking Toward the Future: Management of C. Diff Infection

Evolving Medical Policies and Unmet Needs in C. Diff Infection Management

C. Diff Infection: Patient Access to Fecal Microbiota Transplant

Barriers to Use of Fecal Microbiota Transplant in C. Diff Infection

An Overview of Fecal Microbiota Transplant Use in C. Diff Infection

Challenges in the Management of C. Diff Infection

Payer Perspectives on Risk Stratification for CDI Recurrence

Bezlotoxumab Use in Patients at High Risk for CDI Recurrence

Defining Value in Recurrent CDI

Practical Considerations for Fidaxomicin Use in Recurrent CDI

Dr Natasha Halasa Discusses New Vaccine Surveillance Network Projects

Dr Natasha Halasa Discusses Principal Investigator Responsibilities

Christian John Lillis Lists Benefits of Microbiome-Based Therapeutics for C difficile Treatment

Christian John Lillis on What More Needs to Be Done to Combat C difficile

Christian John Lillis Shares Goals of the Peggy Lillis Foundation's "See C. Diff" Campaign

Dr Natasha Halasa Lists Diarrheal Illness Challenges, Successful Treatment Strategies

Dr Michael Petrosky Speaks on Availability of Monoclonal Antibodies, Further Prevention of RSV

Dr Michael Petrosky Speaks About Monoclonal Antibodies in RSV

Dr Michael Petrosky Discusses Vaccines, Monoclonal Antibodies in RSV

Dr Jessica Allegretti: Major Advancements Being Explored for Prevention, Treatment of CDI

Elevating Equitable Health Care for the LGBTQ+ Community

A Conversation on the Past, Present, and Future of Public Health: NPHW 2023

Elevating Public Health Education for the Next Generation of Advocates

Quelling COVID-19 Also Capped Clostridioides difficile—Will It Continue?